Grow Therapy Secures $88M To Expand Mental Health Services
Grow Therapy's $88 million Series C funding round was led by Sequoia Capital. The financing will help the company invest in its team, improve its product and expand its footprint.
Grow Therapy's $88 million Series C funding round was led by Sequoia Capital. The financing will help the company invest in its team, improve its product and expand its footprint.
Here is a list of some of the biggest funding rounds in the payer/employer space that were announced this month.
Knownwell's $20 million Series A funding round was led by A16Z and included participation from Flare Capital Partners. The company also launched an adolescent metabolic health program.
Pair Team's $9 million Series A funding round was led by Next Ventures and included participation from PTX Capital, Create Health Ventures, OCA Ventures, CHCF Innovation Fund, Kapor Capital and other investors. In total, Pair Team has raised about $20 million.
Ilant Health launched out of stealth Tuesday. The company serves employers and payers and helps identify patients in need of obesity treatment and matches them to the care best for them.
Midi Health's Series A funding round was led by Google Ventures. In total, Midi Health has raised $40 million, including from Felicis, Semper Virens, Icon, 25M and Operator Collective. The company offers virtual care for those going through perimenopause or menopause.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Evvy's $14 million funding round was led by Left Lane Capital and included participation from General Catalyst, LabCorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue and Amboy Street Ventures. In total, Evvy has raised $19 million.
MedArrive's new $8 million funding was led by Cobalt Ventures, a subsidiary of Blue Cross and Blue Shield of Kansas City. With the funding, the company will grow its team, as well as improve on its product and technology, said Dan Trigub, CEO and co-founder of MedArrive.
Kindbody's $100 million funding, announced last week, was led by Perceptive Advisors. It brings the company’s total equity and debt funding to more than $290 million and its valuation to $1.8 billion. It will use the money to add 10 new locations.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The funding round was led by Distributed Ventures and included participation from Idealab NY and Elements Health Ventures. Tuned plans to use the funding to contract with more employers and third party administrators, said Danny Aronson, co-founder and CEO of the startup.
New York healthcare startups received $3.9 billion of funding in 2022, compared to $9 billion in 2021, according to a new DHNY report. Biotech startups represented 22% of total funding in 2022, a stark difference from women’s health only representing 2%.
The $58 million funding round was led by Portage and included participation from PruVen Capital, Wing Venture Capital and others. With the funding, Angle Health plans to expand into additional markets and grow its membership.
Override provides chronic pain patients with a care team that includes a pain physician, a physical therapist, a psychologist and a coach. The company has received $3.5 million in seed funding and has acquired Take Courage Coaching.
The funding was led by Bold Capital Group. Other investors of the company include Khosla Ventures, WestRiver Group and Glico. In total, Viome has raised more than $150 million.